HCA Healthcare Inc (NYSE:HCA) SVP Jane D. Englebright sold 1,995 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $137.50, for a total value of $274,312.50. Following the transaction, the senior vice president now owns 10,480 shares of the company’s stock, valued at $1,441,000. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of HCA opened at $134.49 on Friday. The stock has a 50 day simple moving average of $125.45 and a 200 day simple moving average of $127.74. HCA Healthcare Inc has a 52-week low of $110.31 and a 52-week high of $147.42. The firm has a market capitalization of $45.84 billion, a PE ratio of 13.77, a P/E/G ratio of 1.14 and a beta of 0.90.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $2.23 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.13 by $0.10. HCA Healthcare had a negative return on equity of 173.49% and a net margin of 6.98%. The business had revenue of $12.69 billion during the quarter, compared to analyst estimates of $12.48 billion. During the same period in the previous year, the firm earned $2.16 EPS. HCA Healthcare’s quarterly revenue was up 10.9% compared to the same quarter last year. As a group, research analysts anticipate that HCA Healthcare Inc will post 10.53 EPS for the current fiscal year.
Several institutional investors and hedge funds have recently modified their holdings of HCA. Westside Investment Management Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $34,000. Doyle Wealth Management acquired a new position in HCA Healthcare during the 2nd quarter worth approximately $34,000. Prime Capital Investment Advisors LLC acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $39,000. North Star Investment Management Corp. acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $42,000. Finally, Coastal Investment Advisors Inc. acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $42,000. Institutional investors and hedge funds own 70.33% of the company’s stock.
HCA has been the subject of several analyst reports. Barclays boosted their target price on HCA Healthcare from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. ValuEngine upgraded HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. UBS Group boosted their target price on HCA Healthcare from $165.00 to $168.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Stephens set a $150.00 target price on HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Finally, Bank of America upgraded HCA Healthcare from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $130.00 to $137.00 in a research report on Friday, September 6th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $155.07.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: CBOE Russell 2000® Volatility Index
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.